CASE REPORT Shibdas Chakrabarti, Srikar Darisetty, Nitesh Gupta, Pranav Ish Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India Masking of obstructive sleep apnoea by drug induced central sleep apnoea Abstract Benzodiazepines are widely prescribed hypnotic agents which have multiple proven neurological and respiratory side effects. However, literature is sparse with regards to the incidence and occurrence of new onset central sleep apnoea in individuals being treated with benzodiazepines for insomnia. We present a case report of a patient presenting with new onset central sleep apnoea secondary to long term usage of benzodiazepines, with resultant masking of his pre-existing obstructive sleep apnoea. Key words: central sleep apnoea, benzodiazepines, obstructive sleep apnea Adv Respir Med. 2019; 87: 189–193 Introduction lence, mild cognitive impairment and nocturia for a period of 1 year. He had a past history of Benzodiazepines are the most widely prescri- usage of tablet alprazolam 0.5 mg at night time, bed hypnotic agents for the short-term manage- which was prescribed by a medical practitioner ment of insomnia [1]. These agents normally exert for treatment of insomnia for the past six mon- their influence by decreasing the sleep latency ths. The patient had an Epworth sleepiness score and prolongation of total sleep time [2], however, (ESS) of 15. His body mass index (BMI) was 22. they worsen sleep quality by decreasing REM and The man was a non-smoker. On evaluation, his N3 stages of sleep. Other possible side effects inc- pulmonary function test and echocardiography lude tolerance to the hypnotic effects [3], rebound were within normal limits. There was no history insomnia upon abrupt discontinuation, reduced of any cardiovascular or cerebrovascular event. slow wave sleep [4, 5] and withdrawal effects. The man underwent a diagnostic polysomn- However, literature with regard to the incidence graphy (PSG) Level 1 which recorded the presence and occurrence of new onset central sleep apnoea of central apnoeic events (Figure 1, 2). He had an (CSA) in individuals being treated with benzo- apnoea-hypopnoea index (AHI) of 20 with more diazepines for insomnia is limited to case reports than fifty percent of events being central, hence with sparse texts on the pathophysiology behind a diagnosis of CSA was made in accordance it. We present a case of a patient with new onset with the American Academy of Sleep Medicine central sleep apnoea secondary to long-term usage (AASM) guidelines [6]. of benzodiazepines, with resultant masking of The PSG was scored manually by a sleep his pre-existing obstructive sleep apnoea (OSA). physician. In consultation with a psychiatrist, alprazolam was discontinued and the patient was Material and methods initiated on non-benzodiazepine medication (zol- pidem 5 mg once a day). The magnetic resonance A 53-year-old male, with no comorbid ill- imaging (MRI) of the brain was performed to eva- ness in the past, presented to the department of luate CSA associated with neurologic disease; it pulmonary, critical care and sleep medicine with was reported normal. On subsequent evaluation complaints of snoring, excessive daytime somno- after 2 weeks, the patient reported a subjective mild Address for correspondence: Pranav Ish, Department of Pulmonary, Critical Care and Sleep Medicine, VMMC and Safdarjung Hospital, New Delhi, India; e-mail: [email protected] DOI: 10.5603/ARM.2019.0030 Received: 13.12.2019 Copyright © 2019 PTChP ISSN 2451–4934 www.journals.viamedica.pl 189 Advances in Respiratory Medicine 2019, vol. 87, no. 3, pages 189–193 Sp02 — oxygen saturation ; WK — wake; REM — rapid eye movement sleep; Resp events — respiratory events; S — supine; R — right lateral Figure 1. Hypnogram showing numerous central sleep apnoeas and desaturations and poor quality sleep (most time spent in N2 with no REM sleep) REOGA2 and LEOGA2 — right and left electrooculography; F3A2, C4A1, C3A2 and O2A1 — electroencephalograph; CEMG — Chin electromy- ography; mSnore — snoring; T flow — thermistor flow; Can flow — nasal cannula flow; THO — thoracic muscle effort; ABD — abdominal muscle effort; Effort sum — thorax and abdominal effort sum; PulseR — pulse rate; SPO2 — oxygen saturation; Body — body position Figure 2. Polysomnography five-minute window with epoch 421−430 showing central sleep apnoea in view of no effort with no flow improvement in sleep quality with ESS getting bet- te decrease in both airflow and respiratory effort. ter to 11 from an initial value of 15 over a period Usually, there is no snoring, absence of chest-ab- of two weeks. The effect of alprazolam wears off in dominal paradox and the nasal pressure or PAP 2 to 3 days as it has a half-life of around 11 hours. device flow signal is fairly rounded. However, in view of persistent daytime som- Split night titration was done and a conti- nolence, a repeated PSG was planned. Unexpecte- nuous positive airway pressure (CPAP) of 5 cm dly, in the PSG, numerous obstructive hypopno- water was sufficient to abolish all the obstructive eas were recorded with an AHI of 32 (Figure 3–5). apnoea and hypopnoea events, however, few hy- There was a complete absence of central ap- popnoeas persisted in supine REM sleep leading noeas and hypopnoeas. The present study did to a „good titration” according to the AASM not use the esophageal pressure measurements; guidelines [6]. The sleep quality improved with differentiation between obstructive and central supine REM achieved after continuous positive hypopnoea was performed manually. In general, airway pressure (CPAP) titration (Figure 6, 7). The central hypopnoeas are defined by a proportiona- patient was continued on tablet zolpidem for one 190 www.journals.viamedica.pl Shibdas Chakrabarti et al., OSA masked by CSA Sp02 — saturation of oxygen; WK — wake; REM — REM sleep; S — supine; R — right lateral; IPAP — inspiratory positive airway pressure; EPAP — expiratory positive airway pressure Figure 3. Hypnogram showing disappearance of central events and appearance of obstructive hypopneas in follow-up polysomnography which is titrated with CPAP (green arrow) achieving supine REM REOGM2 and LEOGM2 — right and left electrooculographyl F3M2, C4M1, C3M2 and O2M1 — electroencephalograph; CEMG — Chin electromy- ography; mSnore — snoring; T flow — thermistor flow; Can flow — nasal cannula flow; PatFlow — Patient flow using positive airway pressure device; THO — thoracic muscle effort; ABD — abdominal muscle effort; Effort sum — thorax and abdominal effort sum; PulseR — pulse rate; SPO2 — oxygen saturation; Body — body position; IPAP — inspiratory positive airway pressure; EPAP — expiratory positive airway pressure Figure 4. Polysomnography with ten epochs number 301−310 showing numerous obstructive hypopnoeas more week and prescribed a continuous airway diazepines have been implicated in precipitating pressure of 6 cm water for nocturnal use. The man sleep apnoea, especially central sleep apnoea is currently on follow-up on CPAP only with no (CSA) in patients with heart failure and severe sedative, and reports an improved sleep quality desaturations in patients with mild OSA [7]. and reduced daytime symptoms. The Epworth This situation is complicated by many fac- sleepiness score is now 5 with no limitation in tors, misdiagnosis of OSA as insomnia, ease of social and workplace activity. access to certain sedatives and comorbid psy- chiatric diseases. The other contributing factors Discussion are lack of awareness on the part of the physician to recognise the symptoms of choking, snoring, Usage of hypnotics for sleep induction and early morning headache suggestive of OSA and maintenance is the most common short-term ma- worsening of OSA by psychiatric medications. nagement strategy for insomnia. However, benzo- Moreover, if an airway obstruction occurs, aro- www.journals.viamedica.pl 191 Advances in Respiratory Medicine 2019, vol. 87, no. 3, pages 189–193 REOGM2 and LEOGM2 — right and left electrooculography; F3M2, C4M1, C3M2 and O2M1 — electroencephalograph; CEMG — Chin electromy- ography; mSnore — snoring; T flow — thermistor flow; Can flow — nasal cannula flow; PatFlow — Patient flow using positive airway pressure device; THO — thoracic muscle effort; ABD — abdominal muscle effort; Effort sum — thorax and abdominal effort sum; PulseR — pulse rate; SPO2 — oxygen saturation; Body — body position; IPAP — inspiratory positive airway pressure; EPAP — expiratory positive airway pressure Figure 5. Polysomnography with ten epochs number 721−731 showing no residual hypopnoeas on positive airway pressure of 5 cm water 45.9% 43.8% WK (19%) WK (10.6) 4.6% REM (0.0)% REM (14.3)% 1,4% N1 (33.6%) 10.6% N1 (26.7%) 33.6% 19% N2 (45.9%) 26.7% N2 (43.8%) 14.3% N3 (1.4%) N3 (4.6%) WK — wake; REM — rapid eye movement sleep WK — wake; REM — rapid eye movement sleep Figure 6. No REM and minimal N3 stage activity recorded in initial Figure 7. Improvement in sleep quality with REM contributing to 14% polysomnography when patient was taking Alprazolam of sleep after stopping alprazolam and on PAP titration usals allow the patient to correct the apnoea. The occurrence of CSA has been reported Benzodiazepines can prevent arousal by causing by benzodiazepines because as central nervous sedation, thereby worsening the obstruction system depressants, these drugs decrease the and associated desaturation. However, another central respiratory drive which also has been school of thought reasons that as